PUBLICATIONS

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

No.59
CitationHaematologica 235549(2019)
InstituteNara Medical University
1st AuthorK Sakai
AR
PL○(2000/s)
HD
Paper typesBasic research
Main
purpose
Disease
Antiplatelet drug
Anticoagulant drug
Other drugTAGX-0004, ARC1779, caplacizumab(anti vWF antibody)
Clinical specimens
Animal
KeywordArterial Thrombosis; Thrombotic Thrombocytopenic Purpura; aptamer; von Willebrand factor
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.